Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/1999
04/07/1999EP0906273A1 Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
04/07/1999EP0906119A1 Method of treatment
04/07/1999EP0906110A1 Dna vaccine formulations
04/07/1999EP0906096A1 Agent for inhibiting leukocyte invasion of tissues
04/07/1999EP0868182A4 Process for production of piperidine derivatives
04/07/1999EP0770059B1 Substituted benzamidines, their production and their use as medicaments
04/07/1999EP0754227A4 Chimeric complement inhibitor proteins
04/07/1999EP0752884A4 Method of treating auto-immune diseases using type one interferons
04/07/1999EP0647266B1 D-enzyme compositions and methods of their use
04/07/1999EP0570454B1 Novel steroids
04/07/1999CN1213380A Peptide immunogens for vaccination against and treatment of allergy
04/07/1999CN1213379A Peptide derivatives
04/07/1999CN1213378A Antitumor substance extracted from Grifola
04/07/1999CN1213372A Heterocycle-condensed morphinoid derivatives (II)
04/07/1999CN1213368A Hydroxamic acid based collagenase inhibitors
04/07/1999CN1213315A Compositions including calcium influx retardant for inhibiting cell growth
04/07/1999CN1213307A Novel substituted imidazolium compounds
04/07/1999CN1213302A Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide
04/06/1999US5892099 Autoimmune disease, bone disorders, liver damage, cardiovascular disorders
04/06/1999US5892039 Piperazino derivatives as neurokinin antagonists
04/06/1999US5891894 2-amino oxazole derivatives; antagonists of platelet activating factor useful in treatment of asthma, inflammation, cardiovascular disorders, renal diseases, or as contraceptives
04/06/1999US5891893 5-amino-1,2,4-oxa(or thia)diazoles; antagonists of platelet activating factor useful in treatment of asthma, allergies, inflammation, cardiovascular diseases, renal diseases, or as contraceptives
04/06/1999US5891884 Use of an imidazole derivative for preventing and/or treating rhinitis
04/06/1999US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor
04/06/1999US5891716 An isolated nucleic acid comprising a nucleotide sequence encoding a peptide having at least one epitope recognized by a t cell receptor specific for allergen canis familiaris i or ii; medical diagnosis; antiallergens
04/06/1999US5891667 SpoIIIe polynucleotides
04/06/1999US5891640 Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays
04/06/1999US5891443 Method to produce granulocyte colony stimulating factor from immortalized avian T lymphocytes to produce immortalized cells
04/06/1999US5891438 Method for stimulating production of variable region gene family restricted antibodies through B-cell superantigen vaccination
04/06/1999US5891437 Antigen associated with type I diabetes mellitus
04/06/1999US5891436 The present invention thus provides the basis of an extremely sensitive and specific diagnostic elisa for anti-70 kd antibodies found in pbc.
04/06/1999US5891434 Monoclonal antibodies to the APO-1 antigen
04/06/1999US5891432 Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
04/06/1999CA2248838A1 An intravenous form of thalidomide for the therapy of immunological diseases
04/06/1999CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies
04/02/1999CA2246052A1 Novel hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof
04/01/1999WO1999015703A1 Inhibition of an fgf-binding protein using ribozymes
04/01/1999WO1999015657A2 53bp2 complexes
04/01/1999WO1999015635A1 Human ste20-like stress activated serine/threonine kinase
04/01/1999WO1999015553A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
04/01/1999WO1999015530A1 Tetrazole-containing rapamycin analogs with shortened half-lives
04/01/1999WO1999015529A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
04/01/1999WO1999015524A1 Thiazole derivatives
04/01/1999WO1999015505A1 1,5-diphenylpyrazole derivatives
04/01/1999WO1999015503A2 Process for making diaryl pyridines useful as cox-2 inhibitors
04/01/1999WO1999015501A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents
04/01/1999WO1999015494A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
04/01/1999WO1999015493A1 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
04/01/1999WO1999015490A1 C3a receptor ligands
04/01/1999WO1999015203A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
04/01/1999WO1999015200A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT
04/01/1999WO1999015199A1 Antigen presenting mesenchymal stem cells
04/01/1999WO1999015190A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits
04/01/1999WO1999015164A1 Amide derivatives for the treatment of diseases mediated by cytokines
04/01/1999WO1999002186A3 Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant
04/01/1999WO1999001117A3 Inhibitors of nf-kappab as activators of hsf and inducers of heat shock proteins
04/01/1999WO1998055615A9 Apaf-1, the ced-4 human homolog, an activator of caspase-3
04/01/1999WO1998052573A9 Triterpene saponin analogs having adjuvant and immunostimulatory activity
04/01/1999WO1998039363A3 Immunotoxins and methods of inducing immune tolerance
04/01/1999DE19742263A1 Neue spezifische Immunophilin-Liganden als Antiasthmatika, Antiallergika, Antirheumatika, Immunsuppressiva, Antipsoriatika, Neuroprotektiva New specific immunophilin ligands as anti-asthmatics, anti-allergic, anti-inflammatory drugs, immunosuppressants, anti-psoriasis, neuroprotective agents
04/01/1999CA2820212A1 Recombinant rsv virus expression systems and vaccines
04/01/1999CA2305350A1 Costimulating polypeptide of t cells, monoclonal antibodies, and the preparation and use thereof
04/01/1999CA2304879A1 New tetracycles, process for their production and pharmaceutical preparations containing these compounds
04/01/1999CA2304451A1 Specific immunophilin ligands useful as anti-asthmatic, anti-allergic, anti-rheumatic, immunosuppressive, antipsoriatic and neuroprotective agents
04/01/1999CA2304268A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits
04/01/1999CA2304162A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
04/01/1999CA2303943A1 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
04/01/1999CA2303883A1 C3a receptor ligands
04/01/1999CA2303405A1 53bp2 complexes
04/01/1999CA2303359A1 1,5-diphenylpyrazole derivatives
04/01/1999CA2302339A1 Antigen presenting mesenchymal stem cells
04/01/1999CA2300051A1 Amide derivatives for the treatment of diseases mediated by cytokines
04/01/1999CA2272605A1 Pharmaceutical composition containing gp34 binding-inhibitory agent as effective ingredient
04/01/1999CA2246004A1 A kringle-related clone, hthbz47
03/1999
03/31/1999EP0905238A2 Pigrl-1, a member of immunoglobin gene superfamily
03/31/1999EP0905237A2 PIGR-2 A member of immunoglobulin gene superfamily
03/31/1999EP0905234A2 Allelic variant of human STAT3
03/31/1999EP0905233A2 Staphylococcus aureus trigger factor
03/31/1999EP0905126A1 Metalloproteinase inhibitors
03/31/1999EP0904374A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
03/31/1999EP0904369A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
03/31/1999EP0904367A1 Scf analog compositions and methods
03/31/1999EP0904351A1 Animal cells and processes for the replication of influenza viruses
03/31/1999EP0904299A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
03/31/1999EP0904293A1 An interleukin-5 antagonist
03/31/1999EP0904292A1 Growth differentiation factor-14
03/31/1999EP0904281A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
03/31/1999EP0904280A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
03/31/1999EP0904278A1 Apoptosis inducing molecule ii
03/31/1999EP0904108A1 METHODS FOR TREATMENT OF ALLERGIC DISEASES WITH IgE
03/31/1999EP0904105A1 Novel compounds
03/31/1999EP0904104A1 Novel compounds
03/31/1999EP0904103A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE GLUTAMYL tRNA SYNTHETASE FAMILY
03/31/1999EP0904073A1 Zwitterionic compositions and methods as biological response modifiers
03/31/1999EP0904072A1 Methods of treating immunopathologies using polyunsaturated fattyacids
03/31/1999EP0877733A4 Process for production of piperidine derivatives
03/31/1999EP0762886A4 Icam-1/lfa-1 short-chain peptides and method of using same
03/31/1999EP0750507A4 PROTEASOME REGULATION OF NF--g(k)B ACTIVITY
03/31/1999EP0733035B1 Tricyclic derivatives, pharmaceutical compositions containing them
03/31/1999CN1212696A Pyrimido [5,4-d] pyrimidines, medicaments containing these componds, their use and process for their production
1 ... 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 ... 1172